Completed NA INTERVENTIONAL 2-arm NCT01267942

Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Enhancin in Prevention of Postadenotonsillectomy Morbidity.

Single Intraoperative Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Full Oral Course in Prevention of Post Adenotonsillectomy Morbidity:A Randomised Clinical Trial.

Sponsor: University of Nairobi

Conditions Adenotonsillar Hypertrophy,Under 12 Years.

Interventions Enhancin

Updated 6 times since 2017 Last updated: Dec 28, 2010 Started: May 31, 2008 Primary completion: Oct 31, 2008 Completion: Oct 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Adenotonsillar Hypertrophy,Under 12 Years., this trial is completed. The trial is conducted by University of Nairobi and has accumulated 6 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2017 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Nairobi

Data source: University of Nairobi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nairobi, Kenya